Kala Pharmaceuticals, Inc. - KALA

SEC FilingsOur KALA Tweets

About Gravity Analytica

Recent News

  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 05.29.2025 - KALA BIO to Present at Jefferies Global Healthcare Conference
  • 05.14.2025 - KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
  • 03.31.2025 - KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
  • 03.05.2025 - TD Cowen 45th Annual Health Care Conference
  • 02.26.2025 - KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
  • 02.12.2025 - KALA BIO Announces Chief Executive Officer Transition

Recent Filings

  • 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.14.2025 - 8-K Current report
  • 05.14.2025 - EX-99.1 EX-99.1
  • 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 04.11.2025 - 8-K Current report
  • 03.31.2025 - 424B5 Prospectus [Rule 424(b)(5)]
  • 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
  • 03.31.2025 - 8-K Current report
  • 03.31.2025 - EX-99.1 EX-99.1
  • 03.10.2025 - 4 Statement of changes in beneficial ownership of securities